Chicago Partners Investment Group’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-400
Closed -$15K 396
2018
Q3
$15K Hold
400
﹤0.01% 734
2018
Q2
$15K Sell
400
-34
-8% -$1.23K ﹤0.01% 712
2018
Q1
$15K Buy
434
+34
+9% +$1.21K ﹤0.01% 689
2017
Q4
$15K Hold
400
﹤0.01% 676
2017
Q3
$15K Hold
400
﹤0.01% 695
2017
Q2
$15K Buy
+400
New +$14K ﹤0.01% 538
2017
Q1
Sell
-400
Closed -$13K 546
2016
Q4
$13K Hold
400
﹤0.01% 415
2016
Q3
$14K Hold
400
0.01% 393
2016
Q2
$14K Hold
400
0.01% 337
2016
Q1
$14K Hold
400
0.01% 322
2015
Q4
$16K Hold
400
0.01% 357
2015
Q3
$15K Hold
400
0.01% 305
2015
Q2
$17K Sell
400
-3
-0.7% -$129 0.01% 309
2015
Q1
$17K Buy
403
+3
+0.8% +$125 0.01% 301
2014
Q4
$17K Buy
+400
New +$16.4K 0.01% 302

Other funds holding BME

Chicago Partners Investment Group's BME Position: Q4 2018 in Review

Chicago Partners Investment Group sold out of BlackRock Health Sciences Trust (BME) in Q4 2018, closing a stake of 400 shares — an estimated $15K sold.

Chicago Partners Investment Group first reported a position in BME in Q4 2014 and held it in 15 quarters. The position peaked at $17K in Q2 2015. 42 funds tracked by Wall St. Rank hold BME as of Q4 2018.

  • Chicago Partners Investment Group reported no remaining BlackRock Health Sciences Trust position as of Q4 2018 after selling out during the quarter.
  • Chicago Partners Investment Group sold 400 BlackRock Health Sciences Trust shares in Q4 2018, an estimated $15K.
  • Chicago Partners Investment Group first reported a position in BlackRock Health Sciences Trust in Q4 2014 and held it in 15 quarters.
  • Chicago Partners Investment Group's BlackRock Health Sciences Trust position peaked at $17K in Q2 2015.
  • 42 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2018.

Based on Chicago Partners Investment Group's 13F filing for Q4 2018, filed 11 Jan 2019.